OICR NEWS

OICR News

OICR accelerates cancer research to produce better health in the province. We do this by supporting talent, technology, commercialization and collaboration.

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Clear all filters

Filtered stories

Showing: Collaboration

CollaborationAll cancers

Making precision oncology more equitable: Findings from the Lancet Oncology Commission

OICR’s Dr. Lincoln Stein and Dr. Mélanie Courtot were part of an expert international commission to understand and overcome challenges in precision oncology. The results of a global commission on equity in precision oncology were…

ArticleSep 25, 2026

CollaborationClinical trials

How cancer research can put patients first

OICR Investigator Dr. Bishal Gyawali and his Common Sense Oncology movement want to make cancer research and care more patient-centric What matters most in cancer research? For OICR Investigator Dr. Bishal Gyawali, the answer is…

ArticleJun 16, 2026

CollaborationBreast cancer

Massive international clinical trial aims to answer a pivotal question in breast cancer screening

TMIST, co-led by Canadian researchers, is working to determine whether a newer form of breast imaging can better detect aggressive breast cancers. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is one of the largest breast…

ArticleJun 02, 2026

CollaborationDiagnosis

Reimagining the clinical report: How plain language can help patients make informed decisions

In the CAN-PREFER trial, OICR researchers are trialing accessible, patient-friendly reports from cancer biomarker testing. You shouldn’t need a PhD to understand your own cancer. Scientific advances are helping people with cancer live longer, but…

ArticleMay 20, 2026

CollaborationDiagnosis

Ontario collaboration aims to predict and prevent cancer recurrence before it happens

OICR is leading a province-wide initiative to advance molecular residual disease (MRD) research and bring tests to patients. “Did you get it all?” It’s often the first question a patient asks after cancer treatment, and…

ArticleApr 13, 2026

Collaboration

OICR-supported research to help immunocompromised cancer patients get vaccinated

The Waterloo-based study will advance the use of a vaccine decision tool for healthcare professionals tailored to cancer patients’ needs. A research team at the University of Waterloo School of Pharmacy is advancing cancer care…

ArticleMar 18, 2026

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

OICR News

Discover the latest news and insightsDiscover the latest news and insights

Filtered stories

Making precision oncology more equitable: Findings from the Lancet Oncology Commission

How cancer research can put patients first

Massive international clinical trial aims to answer a pivotal question in breast cancer screening

Cancer solved together — in your inbox

Reimagining the clinical report: How plain language can help patients make informed decisions

Ontario collaboration aims to predict and prevent cancer recurrence before it happens

OICR-supported research to help immunocompromised cancer patients get vaccinated